Item 7.01 Regulation FD Disclosure

On September 16, 2021, USANA Health Sciences, Inc. issued a press release announcing preliminary financial results for the third quarter ended October 2, 2021 along with updated outlook for the full fiscal year 2021. A copy of the press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K. The information contained in this Item 7.01 and Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.



Item 9.01      Financial Statements and Exhibits.

              (d) Exhibits

Exhibit No.     Description
99.1            Press release issued by USANA Health Sciences, Inc. dated September
                16, 2021 (furnished herewith).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses